HPE
48
2
ZBH
69
15
LEN
21
3
LOW
42
14
CMA
42
3
PEP
33
4
BDX
59
3
SBUX
29
-2
CF
47
5
EMN
40
5
FSLR
50
6
KO
44
2
AZO
46
3
MET
58
2
PPL
44
9
MDLZ
28
2
FOX
71
3
AON
25
4
MKC
54
3
ITW
45
2
HPE
48
2
ZBH
69
15
LEN
21
3
LOW
42
14
CMA
42
3
PEP
33
4
BDX
59
3
SBUX
29
-2
CF
47
5
EMN
40
5
FSLR
50
6
KO
44
2
AZO
46
3
MET
58
2
PPL
44
9
MDLZ
28
2
FOX
71
3
AON
25
4
MKC
54
3
ITW
45
2
Financhill
Back

Puma Biotechnology 10K Form

Sell
43

PBYI
Puma Biotechnology

Last Price:
$2.76
Seasonality Move:
4.34%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive PBYI News And Ratings

See the #1 stock for the next 7 days that we like better than PBYI

PBYI Financial Statistics

Sales & Book Value

Annual Sales: $235.6M
Cash Flow: $11M
Price / Cash Flow: 3.96
Annual Sales: $1.45
Price / Book: 1.9

Profitability

EPS (TTM): 0.47000
Net Income (TTM): $23.2M
Gross Margin: $173M
Return on Equity: 44.22%
Return on Assets: 10.82%

Puma Biotechnology Earnings Forecast

Key Puma Biotechnology Financial Ratios

  • The Gross Profit Margin over the past 16 years for PBYI is 73.40%.
  • The Selling, General & Administrative Expenses for PBYI have been equal to 37.53% of Gross Profit Margin.
  • The Research & Development expenses have been 21.38% of Revenue.
  • The Interest Expense is 61.74% of Operating Income.
  • The Net Earning history of PBYI is 9.16% of Total Revenues.
  • Per Share Earnings over the last 16 years have been positive in 9 years.

Puma Biotechnology Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: PBYI
CUSIP: 74587V
Website: pumabiotechnology.com

Debt

Debt-to-Equity Ratio: 1.1
Current Ratio: 1.42
Quick Ratio: 1.37

Price-to-Earnings

Trailing P/E Ratio: 6.12
Forward P/E Ratio: 4.63

PBYI Technical Analysis vs Fundamental Analysis

Sell
43
Puma Biotechnology (PBYI) is a Sell

Is Puma Biotechnology a Buy or a Sell?